Company
Last deal
$2.4M
Amount
Post-IPO Equity
Stage
13.07.2012
Date
4
all rounds
$12.2M
Total amount
General
About Company
IntegraGen develops molecular markers for CNS and metabolic diseases, leveraging its IP, research expertise, and sample libraries.
Industry
Sector :
Subsector :
founded date
01.01.2000
Number of employees
Company Type
For Profit
Last funding type
Post-IPO Equity
IPO status
Private
Contacts
Phone number
Website URL